Novartis AG wins approval to buy GSK cancer drugs, with conditions

February 23, 2015 5:12 PM

5 0

Novartis AG wins approval to buy GSK cancer drugs, with conditions

WASHINGTON (Reuters) - Novartis AG has won U.S. antitrust approval to buy GlaxoSmithKline’s oncology drugs, with conditions, the U.S. Federal Trade Commission said on Monday.

Canada's competition agency also said on Monday that it would allow the deal to go forward.

Also read: Donald Trump Cabinet Picks Signal Deregulation Moves Are Coming

Read more

To category page

Loading...